Medivation Inc., which is now a part of Pfizer, Inc. is focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation’s goal is to transform the treatment of these diseases and offer hope to critically ill patients and their families. With the approval of Xtandi (enzalutamide) capsules in late August 2012 and the product launch immediately following, Medivation is continuing to build and develop a world-class workforce to take the company to the next strategic level.
Medivation was founded in 2004 by a group of experienced professionals with a long track record of working together successfully as a team in the pharmaceutical and biotechnology industries. They founded Medivation to leverage that expertise to bridge the medical product development gap between early-stage development and product launch.
Medivation currently has 500+ employees located in beautiful downtown San Francisco, CA. For additional company information, please visit our website at www.medivation.com.
HealthTrack, formerly known as HealthTrackRx, is a nationwide diagnostics company delivering next-morning molecular testing solutions for urgent care and walk-in clinics, women’s health, and pediatric providers.
Through advanced molecular diagnostics, clinically focused testing, and rapid turnaround times, HealthTrack helps providers diagnose with confidence, support timely treatment decisions, and improve patient outcomes.
Headquartered in Louisville, Kentucky, near UPS Worldport, HealthTrack combines clinically focused innovation, rapid turnaround times, and nationwide scale to help providers deliver faster, more confident care.
To learn more, visit healthtrack.com.
Interested in joining our team? Visit healthtrack.com/careers.
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.